First National Bank of Omaha’s AngioDynamics ANGO Stock Holding History

First National Bank of Omaha’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-41,215	Closed	-$419K	–	345
2020 Q2	$419K	Sell	41,215 -192	-0.5%	-$1.98K	0.03%	277
2020 Q1	$432K	Buy	41,407 +490	+1%	+$6.15K	0.03%	263
2019 Q4	$655K	Buy	40,917 +1,011	+3%	+$15.4K	0.04%	264
2019 Q3	$735K	Sell	39,906 -3,042	-7%	-$59.5K	0.05%	244
2019 Q2	$846K	Buy	42,948 +275	+0.6%	+$5.6K	0.06%	223
2019 Q1	$976K	Buy	42,673 +5,873	+16%	+$128K	0.07%	208
2018 Q4	$741K	Sell	36,800 -4,262	-10%	-$88.2K	0.06%	229
2018 Q3	$893K	Buy	41,062 +6,227	+18%	+$138K	0.05%	296
2018 Q2	$775K	Buy	+34,835	New	+$712K	0.05%	303

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

First National Bank of Omaha's ANGO Position: Q3 2020 in Review

First National Bank of Omaha sold out of AngioDynamics (ANGO) in Q3 2020, closing a stake of 41,215 shares — an estimated $419K sold.

First National Bank of Omaha first reported a position in ANGO in Q2 2018 and held it in 9 quarters. The position peaked at $976K in Q1 2019. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2020.

First National Bank of Omaha reported no remaining AngioDynamics position as of Q3 2020 after selling out during the quarter.
First National Bank of Omaha sold 41,215 AngioDynamics shares in Q3 2020, an estimated $419K.
First National Bank of Omaha first reported a position in AngioDynamics in Q2 2018 and held it in 9 quarters.
First National Bank of Omaha's AngioDynamics position peaked at $976K in Q1 2019.
138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2020.

Based on First National Bank of Omaha's 13F filing for Q3 2020, filed 6 Nov 2020.